How could sharing of data among researchers conducting clinical trials lead to better progress against cancer and more benefit for patients?
Is the end of cancer as a deadly disease now possible? Can we actually win the war on cancer, which has been pronounced a failure by many?
Taking a look back at major stories about developments in cancer research and breast cancer in 2015.
What’s exciting in cancer research right now? This post reviews several of the most interesting cancer research stories that have been in the news this Summer.
New discoveries about the role of the hormone progesterone in breast cancer could potentially lead to improved treatment options for many breast cancer patients.
Ken Burns’ cancer film is a compelling story of the progress that’s been made against cancer over the last several decades, but it also makes clear the need for continuing investment in research to build on that progress.
The 2014 San Antonio Breast Cancer Symposium featured new approaches, including immune system therapies, that could eventually have a big impact on the way breast cancer is treated.
In “adaptive” clinical trial design, the goal is to identify as rapidly as possible new drug therapies that show a likelihood of being successful in specific patient populations.
My top five takeaways from the 2013 San Antonio Breast Cancer Symposium.
A new set of findings from The Cancer Genome Atlas project looks at cancer genome sequencing in a different way–comparing mutations across types of cancer.